Major adverse cardiovascular events and hyperuricemia during tuberculosis treatment

BACKGROUND: Hyperuricemia is common during tuberculosis (TB) treatment, especially in association with pyrazinamide (PZA). This study investigated the relationship between major adverse cardiovascular events (MACEs) and hyperuricemia during TB treatment. METHODS: We conducted a single-center retrosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Hong-Joon, Yoon, Joon-Young, Na, Young-Ok, Lee, Jae-Kyeong, Kho, Bo Gun, Kim, Tae-Ok, Kim, Yu-Il, Lim, Sung-Chul, Jeong, Sae-Hee, Kwon, Yong-Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653473/
https://www.ncbi.nlm.nih.gov/pubmed/37972037
http://dx.doi.org/10.1371/journal.pone.0294490

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653473/
https://www.ncbi.nlm.nih.gov/pubmed/37972037
http://dx.doi.org/10.1371/journal.pone.0294490

Ejemplares similares